By harnessing the power of AI, Sibme will boost the effectiveness of instructional coaching and save teachers’ time as they receive data and feedback in real time on how they conduct their classroom lessons. Photo via Getty Images

Not many adages stand the test of time quite like this one: to be the best, learn from the best.

Sage advice, which is why Houston-based Sibme, the learning engagement platform designed by teachers, is introducing an all-new artificial intelligence tool to transform professional learning for teachers.

By harnessing the power of AI, Sibme will boost the effectiveness of instructional coaching and save teachers’ time as they receive data and feedback in real time on how they conduct their classroom lessons. This is accomplished by providing teachers with more opportunities for meaningful, in-depth conversations with their instructional coaches through automatically generated quantitative data on video and audio recordings of teachers’ classroom instruction.

“When David Wakefield founded the company in 2013, it was primarily based on something that was pretty difficult to do at the time, which was just being able to record and upload video in classrooms,” COO TJ Hoffman tells InnovationMap. “Sibme was the first mobile-first technology that made it possible to upload a video longer than an hour into the cloud. And that was sort of our original approach in the classrooms.

Wakefield and Hoffman were former teachers, with former working in Houston ISD, and the latter in Pasadena ISD.

"We recognized that a lot of the ways in which teachers are trained in traditional workshops, or trainings like modules online and stuff like that, weren't in any way improving our ability to do our jobs as teachers," Hoffman says. “And the thing that really did make it easy for us to grow as teachers was watching other teachers teach and being able to ask them questions and that sort of stuff.

"It's hard to do in schools because teachers are in classrooms with kids all day long," Hoffman continues. "There's no time for them to leave and go watch someone else do their job. So that idea of recording a video and annotating it with comments and asking feedback three minutes in, like ‘Hey, why did you ask that question of that student that way?’ That was something that we originally did, and that's been the primary driver of our growth over the last ten years.”

Efficient education for the educators

With the tagline, “making every moment a teachable moment,” Sibme has broken through as the go-to learning engagement platform for professional development, replete with coaching, cohort-based professional learning communities and peer-to-peer collaboration.

“The thing that we've recognized and have worked on for the last couple of years is, if I record and upload a 45-minute lesson and share it with the teacher next door or the principal at the school or somebody else, they've got to watch it for 45 minutes and that's time-consuming as well,” says Hoffman. “Our newest iteration, our AI tools, make it easier to identify key moments in a video that are related to things that a teacher can do better to reach kids more equitably and more effectively so that they're learning better.”

Not surprisingly, the creators of Sibme are excited about the AI component, which is able to watch the videos, transcribe them and identify key moments where the teacher asks important questions in those videos.

“Now with the AI tool, I can go straight to those moments and see which kids I have called on, what kinds of questions I have asked them, who responded and who hasn't, so it helps teachers develop better strategies for reaching kids.”

Practice makes progress, according to the Sibme platform, which embeds training and collaboration in every workday, engaging employees while building a stronger community of learners.

“Sibme builds off the same principle of athletes,” adds Wakefield. “I can watch a million Astros games, but I'm not going to be a better baseball player until I pick up a bat or pick up a glove and actually start playing and then get coaching on it, right? It's the same principle for training teachers. Teaching is a complex activity. I can't just show you how to teach or tell you how to teach and then you can do it.

“You've got to get up and teach, and then you've got to get really concrete feedback the same way that a great coach provides concrete feedback to a player. Hold the bat a little bit differently or, you know, lean on your left hip. Those real kind of small changes, it's the same thing with a teacher. You know, walk to the left side of the room. Being able to actually provide that feedback on the teacher's work rather than saying, here's how you should teach, which is what training typically does, right? Training is just theory, not actual practice. This is giving teachers an opportunity to rehearse and then get coached by a real coach, whether that coach is someone with a formal title of instructional coach or just the teacher next door.”

Making the network work

Sibme’s novel, yet simple approach to improving teachers via their peers has proven to be much more effective than the typical training methods of the past.

Currently, Sibme works with more than 1,000 innovative schools, districts, and institutions – including Houghton Mifflin Harcourt, ASCD, Scholastic, the University of Texas, and the Houston Independent School District.

“At this point, I believe we're in 40 states,” says Wakefield. “We're also in some international countries. We have some channel partners that have also helped distribute for us. We probably are in every state in the US in some form or another, in a white-labeled version or within our own Sibme platform. We're definitely one of the leaders in our space for this type of next-generation solutions for professional learning and training.”

And as schools nationwide try to battle with teacher retention, Sibme offers its own solution by giving teachers concrete evidence that they are growing and improving as educators. After all, Sibme is an acronym for “Seeing is Believing Me,” which means that teachers will likely stay onboard if they feel that they are succeeding.

“One of our principals said that they don't have a retention problem because they invest so much in teacher excellence,” says Wakefield. “And when teachers feel successful, then they don't leave. They had, I think it was like an 86 percent decline in teacher turnover in one year just from the teachers being able to look at themselves and see that they’re growing and getting better and improving. That has a huge impact on their feelings of success in their jobs.”

A bright future

With more than 10 years under its belt, Sibme hopes the next 10 will offer even more advancements in the professional development space.

“We're sort of in that first sort of initial iteration of our release with AI,” says Wakefield. “That's only going to improve where things will just become more and more automated. The platform is just going to be able to help them do their work much more efficiently in the future. And they can coach and support far more people than they ever could without AI. And the experts can come in and leverage the AI to be so much more effective at their jobs.

“We’ll continue preparing the next generation of teachers, as well as in university teacher prep programs, so that teachers are getting better prepared for the realities of the classroom by getting a lot more reflection and practice.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.